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The plant Momordica cochinchinensis has traditionally been used in Chinese medicine to treat a variety of illnesses. A
range of bioactive molecules have been isolated from this plant, including peptides, which are the focus of this study.
Here we report the isolation and characterization of two novel peptides, MCoCC-1 and MCoCC-2, containing 33 and
32 amino acids, respectively, which are toxic against three cancer cell lines. The two peptides are highly homologous
to one another, but show no sequence similarity to known peptides. Elucidation of the three-dimensional structure of
MCoCC-1 suggests the presence of a cystine knot motif, also found in a family of trypsin inhibitor peptides from this
plant. However, unlike its structural counterparts, MCoCC-1 does not inhibit trypsin. MCoCC-1 has a well-defined
structure, characterized mainly by a triple-stranded antiparallel -sheet, but unlike the majority of cystine knot proteins
MCoCC-1 contains a disordered loop presumably as a result of flexibility in a localized region of the molecule. Of the
cell lines tested, MCoCC-1 is the most toxic against a human melanoma cell line (MM96L) and is nonhemolytic to
human erythrocytes. The role of these peptides within the plant remains to be determined.
Plants have traditionally been rich sources of molecules having
applications as drug leads. Although previous research on plant
natural products has focused on small molecules, recent attention
has turned toward peptides from plants. Peptides hold great promise
as drug leads, but their susceptibility to proteolytic breakdown and
typical lack of oral bioavailability are major potential limitations.
A solution to this problem may be found in plants that produce
exceptionally stable peptides. This study focuses on Momordica
cochinchinensis, a plant that belongs to the Cucurbitaceae family.
The flesh of the fruit is widely used in Vietnam to color rice,1 and
the seeds of the fruit have been widely used as a Chinese medicine,
also known as Mubiezhi, to treat conditions such as hemorrhoids
and hemangiomas.2 Previous studies have also found cytotoxic
compounds in it and other plants from the same genus.3-5 For
example, analysis of an aqueous extract of M. cochinchinensis
revealed a 34 kDa protein, which suppressed proliferation of tumor
cells.1 In addition, M. charantia contains triterpene glycosides,
which also show anticancer activity.6 Given the anticancer com-
ponents already found in the Momordica genus, we were interested
in the discovery of novel peptidic molecules with potential
anticancer applications.
Several trypsin inhibitors have been isolated from M. cochinchin-
ensis, including MCoTI-I, MCoTI-II, and MCoTI-III.7-9 Unusually,
MCoTI-I and MCoTI-II are head-to-tail cyclized peptides, whereas
MCoTI-III is an acyclic peptide. The structure of MCoTI-II has
been determined10,11 and contains a cystine knot motif,12,13 which
comprises an embedded ring formed by two disulfide bonds and
their connecting backbone sequences and a third disulfide bond that
threads the ring. This motif has previously been shown to be
responsible for structural stability in plant-derived cyclic peptides
known as cyclotides.14,15 In both MCoTI-II and the cyclotides the
backbone segments between successive cysteine residues are
referred to as loops.14 Two of them (loops 1 and 4) form the
embedded ring of the cystine knot, and the others (loops 2, 3, 5,
and 6) protrude from the cystine knot core. Figure 1 shows the
sequences of three M. cochinchinensis trypsin inhibitors7 together
with images of the fruit and seeds of the plant. On the basis of the
limited studies on this plant and the interesting peptides already
found, the aim of the current study was to isolate novel peptides
from M. cochinchinensis seed extracts and to test their cytotoxicity
on cancer cell lines. Two novel peptides with toxicity against cancer
cell lines were discovered and structurally characterized.
Results and Discussion
Peptides were extracted from homogenized seeds of M. cochinchin-
ensis in NaOAc buffer, and the crude extract was freeze-dried. An
analytical RP-HPLC trace of the crude extract is shown in Figure
2A. The extract was fractionated using preparative RP-HPLC and
analyzed using EIMS. Two novel peptides were isolated and named
MCoCC-1, for M. cochinchinensis with cytotoxicity activity on
cancer cell lines-1, and MCoCC-2. Both peptides eluted at 29-30
min using a 2% gradient on an analytical RP-HPLC. MCoCC-1
and MCoCC-2 had masses of 3287 and 3169 Da, respectively
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Figure 1. Sequences of previously characterized peptides from M.
cochinchinensis and photographs of the plant’s fruit and seeds. (A)
Sequences are shown for the cyclic peptides MCoTI-I and MCoTI-
II and the acyclic MCoTI-III. Conserved cysteine residues are
highlighted, and the cystine connectivity is labeled with I-IV,
II-V, and III-VI. The loop sequences between the cysteines are
numbered,14 and a thick black line joining the N and C termini
indicates a cyclic backbone. In the MCoTI-III sequence, the pyro-
Glu residue at the N-terminal is represented as ‘<’. This residue
can be determined after treatment with pyroglutamyl aminopepti-
dase.7 (B) From left to right: halved fruit from M. cochinchin-
ensis; the seeds; and the MCoTI-II structure (PDB ID: 1IB9)
showing the antiparallel -sheet with arrows, the short 310 helix
as a ribbon, the disulfide bonds in yellow ball and stick format,
and several labeled loops.
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(Figure 2B). MCoCC-1 was more abundant, and consequently easier
to purify, than MCoCC-2 and, thus, was the major focus of the
functional and structural experiments performed in this study.
To determine whether these peptides contained disulfide bonds,
they were treated with the reducing agent tris(2-carboxyethyl)phos-
phine hydrochloride (TCEP), and a mass increase of 6 Da was
observed, suggesting that three disulfide bonds had been reduced.
Both peptides were reduced and digested with a combination of
trypsin and chymotrypsin, followed by sequencing by tandem mass
spectrometry. Figure 3 shows an example nanospray MS spectrum
of an MCoCC-2 fragment after it was digested by chymotrypsin.
The sequences of both peptides were derived from analysis of the MS
fragmentation patterns (see Supporting Information, Table 1S), and
their amino acid compositions were verified using high-sensitivity
amino acid analysis results (see Supporting Information, Table 2S). It
should be noted that MCoCC-1 and MCoCC-2 were not cleaved at
the single Leu residue in the sequence during chymotrypsin digestion
for the nanospray analysis, and NMR analysis was required to
determine the sequence position of the Ile and Leu residues. In
particular, DQF-COSY spectra, which only have up to three-bond
correlations, were used to distinguish between the two residues.
Although leucine and isoleucine are equivalent in molecular weight,
different couplings are observed in the COSY spectrum as a result of
the different side chain configurations.
MCoCC-1 and MCoCC-2 comprise 33 and 32 amino acid residues,
respectively, and differ by only two residues (Figure 2B). Neither
peptide is homologous to any peptide found in the SWISS PROT
database. Aside from having six cysteine residues, they share no
sequence similarity and have different loop spacings from known M.
cochinchinensis peptides, i.e., MCoTI-I, MCoTI-II, and MCoTI-III,
as shown in Figure 1A. Thus, they represent a novel class of peptides.
Determining the connectivity of disulfide bonds in disulfide-rich
peptides can be complicated by the presence of tightly folded
structures and the proximity of multiple disulfide bonds within these
molecules.16 Nevertheless, selective reduction of the disulfide bonds
followed by derivatization of the cysteine residues and sequence
analysis has been successfully used to determine the disulfide
connectivity of a range of peptides.17 This approach was tried for
MCoCC-1, but the selective reduction procedure failed to yield
partially reduced fragments, and only the fully oxidized and fully
reduced species were observed in the RP-HPLC traces (results not
shown). Given the lack of partially reduced intermediates observed
during the reduction of MCoCC-1, an NMR approach was used in
an attempt to determine the disulfide connectivity. Although such
an approach may also be complicated by the tightly folded structures
of disulfide-rich peptides,18 it has proved successful in a number
of cases.19,20 TOCSY and NOESY spectra were recorded and
showed well-dispersed peaks, as well as a large number of NOE
cross-peaks, which is indicative of a well-defined structure (see
Supporting Information, Figure 3S). NMR assignments for MCoCC-1
were made using established techniques,21 and the complete
assignment of chemical shifts is shown in Table 4S (Supporting
Information). The only complication was that the amide proton
signals of Leu9 and Ser12 were not observed in the NMR spectra,
suggesting that both residues may reside in a conformationally
flexible region of the molecule and the signals are consequently
broadened beyond detection.
Analysis of the NMR RH secondary shifts provided a first
indication of the secondary structure of MCoCC-1. In general
several consecutive positive RH secondary shifts22 indicate the
presence of -sheet structures. Conversely, stretches of negative
secondary shifts indicate the presence of helical structures. The RH
secondary shifts of MCoCC-1 are shown in Figure 4A, and on the
basis of the significant number of positive values it can be deduced
that MCoCC-1 has a -strand structure in the C-terminal region.
Three-dimensional structures were calculated using 195 distance
restraints and 13 dihedral angle restraints derived from the NMR
data. Two approaches were used in an attempt to determine the
Figure 2. RP-HPLC elution profile of M. cochinchinensis seed
extract and the sequences of MCoCC-1 and MCoCC-2. (A) The
elution profile is an analytical RP-HPLC trace using a 2% gradient
with a flow rate of 0.3 mL/min and demonstrates the close elution
times of MCoCC-1 and MCoCC-2 as expected from their high
sequence homology. The elution profile also shows the previously
characterized cyclic peptides, MCoTI-I and MCoTI-II. (B) Sum-
mary table of the sequences and molecular weights of MCoCC-1
and MCoCC-2.
Figure 3. Nanospray MS data after chymotrypsin digestion of the
MCoCC-2 peptide. The precursor ions obtained following cleavage
with chymotrypsin are shown. MS/MS fragmentation on selected
precursor ions was used to deduce the amino acid sequence.
505.712+ is the precursor ion that resulted after the cleavage
following a phenylalanine residue (marked with an asterisk) and
was used to deduce the first half of the sequence (GCEGKPCGLF).
Both 728.293+ and 1091.942+ correspond to precursor ions for the
second half of the sequence (RSCGGGCRCWPTVTPGVGICSS).
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disulfide bond connectivity. In the first approach, initial structures
were calculated without restraints on any disulfide bonds and the
distances between the sulfur atoms for each possible pair of the
cysteine residues were measured to determine the most likely
disulfide bonds based on proximity. The results of this analysis
are shown in Table 1. The most probable disulfide bond was found
to be between Cys7 and Cys19. The next most probable bond was
between Cys7 and Cys30, but this is inconsistent with the first
disulfide bond, making it difficult to determine the complete
connectivity using this approach. The limitation of this simple
approach was previously seen in the structural analysis of kalata
B1, a 29-residue plant-derived cyclic peptide found in Oldenlandia
affinis, also with three disulfide bonds.14,23 A more sophisticated
approach was thus undertaken. This involved calculating structures
with different possible disulfide bond connectivities and comparing
the energies of these structures to determine which connectivity
best satisfied the experimental restraints.18 From the 15 possible
combinations of three-disulfide bond connectivities, only four of
these combinations had few experimental restraint violations. In
these four sets of connectivities, the Cys7-Cys19 connectivity was
present in three. The results from the analysis are given in Table
2. An overlay of the 20 lowest energy structures and the lowest
energy structure for sets 3 and 4, the two sets with the lowest
experimental restraint violations, are illustrated in Figure 4B.
Despite the differences in disulfide connectivity the overall folds
of all four sets are very similar, indicating that different connec-
tivities can be accommodated without significant disruption to the
structure. However, set 3 is the most likely disulfide bond
connectivity, as this structure had the lowest NOE, dihedral, and
overall energies when compared to energies obtained without
disulfide connectivities. Encouragingly, it includes the Cys7-Cys19
connectivity deduced as being present from the simple distance
protocol noted above.
The 20 lowest energy structures of set 3 are in good agreement
with the experimental data, showing no dihedral angle violation
exceeding 3° and no distance violation more than 0.3 Å (Supporting
Information, Table 5S). Analysis of the secondary structure was
done with PROMOTIF24 and revealed that an antiparallel -sheet
is the major element of secondary structure, comprising strands
involving residues 5-8, 19-21, and 27-30. In addition, there is a
type II -turn at residues 24-27. These structural findings are
consistent with the RH secondary shift analysis, which suggested that
the C-terminal region of MCoCC-1 adopts an extended -strand
structure. The disulfide bonds of set 3 (Cys2-Cys17; Cys7-Cys19;
Cys13-Cys30) form a cystine knot motif, and the loop between
Cys7-Cys13 is disordered, as shown in Figure 4B. The disorder is
probably due to flexibility in this loop. Interestingly, the N- and
C-termini of the structure are in close proximity to each other.
Although MCoCC-1 has no sequence similarity to previously
characterized peptides, the cystine knot motif seen in it is prevalent in
a wide range of organisms. Indeed, a recent paper noted that the cystine
knot25 topology is found in nearly 40% of known Cys-rich peptide
domains and is the most commonly observed structural motif. It is
likely that this motif is prevalent because it confers significant stability
to the fold. Despite the stability conferred by the cystine knot, one
loop of MCoCC-1 (between residues Cys7 and Cys13) is quite
disordered, most likely as a result of structural flexibility in this region.
Although this is unusual, it is not unprecedented, and, for example,
other cystine knot molecules such as kalata B826 and MCoTI-II10,11
have individual loops that are disordered.
Biological assays were conducted to characterize the two novel
peptides. MCoCC-1 was tested in all assays, but MCoCC-2 was
tested only in the cytotoxicity assay because of limited amounts of
material. Cytotoxicity assays were conducted to examine the effect
of the peptides against four human cell lines, including human
colorectal adenocarcinoma (HT29), human lung carcinoma cells
(A549), human melanoma cell line (MM96L), and a noncancerous
control neonatal foreskin fibroblast cell line (NFF). An M. cochinchin-
ensis seed extract was also tested in this assay for comparison with
the purified peptides. The highest level of cytotoxicity found for
MCoCC-1 was against the MM96L cell line, which showed 57%
cell survival in the presence of 2 µM MCoCC-1. By contrast, the
control NFF cell line exhibited 89% cell survival at this concentra-
Figure 4. RH secondary shifts of MCoCC-1 determined from 1H
NMR spectra measured at 290 K and structures of MCoCC-1
calculated with two alternative disulfide bond connectivities. (A)
The RH secondary shifts were calculated by subtracting the random
coil 1H NMR chemical shifts of Wishart et al.22 from the measured
RH chemical shifts. A cyan arrow below the stretch of consecutive
amino acids having positive RH secondary shifts near the C-
terminus supports the presence of a -strand in this region. (B) A
superposition of the 20 lowest energy structures for the two sets of
disulfide connectivities is shown on the left with the disulfide bonds
in red. The lowest energy structure is shown on the right with the
disulfide bonds shown in ball and stick format. Cysteine residues
are labeled in red: set 3 (Cys7-Cys19; Cys13-Cys30; Cys2-Cys17);
set 4 (Cys2-Cys17; Cys7-Cys30; Cys13-Cys19). The diagram
was created in MolMol.38
Table 1. Mean S-S Distances (Å) in the MCoCC-1 Structures
Calculated without Disulfide Bond Restraints
bond (Cys-Cys pair) mean distancea(Å) orderb
2-7 11.76 13
2-13 5.64 4
2-17 5.64 5
2-19 13.48 15
2-30 7.89 8
7-13 10.66 12
7-17 9.18 10
7-19 3.35 1
7-30 4.27 2
13-17 8.73 9
13-19 12.89 14
13-30 7.79 7
17-19 9.97 11
17-30 5.39 3
19-30 6.03 6
a Mean distance between sulfur atoms of the indicated residues
calculated from the 20 lowest energy structures. b Rank order of mean
distances.
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tion. Similarly, the highest and lowest cytotoxicity observed for
MCoCC-2 treatments at 1.3 µM were 51% cell survival for the
MM96L cell line and 86% cell survival for the NFF cell line,
respectively, as shown in Figure 5. These findings highlighted that
both peptides not only have similar sequences but also have similar
cytotoxicity on MM96L and NFF cell lines. The M. cochinchinensis
seed extract had potent cytotoxicity at 5 µg/mL on all cancer cell
lines, with 0% cell survival for the MM96L cell line and 31% cell
survival for the control NFF cell line. Thus, the M. cochinchinensis
seed extract has more potent cytotoxicity on cancer cell lines than
the isolated peptides, indicating that there are probably additional
cytotoxic components that remain to be identified in the extract.
Although the cytotoxic activity for both MCoCC-1 and MCoCC-2
was not significantly different between all cancer cell lines,
encouragingly, both peptides caused approximately 50% cell death
on the MM96L cell line.
As other disulfide-rich peptides isolated from M. cochinchinensis
are trypsin inhibitors,7 MCoCC-1 was tested for trypsin inhibitory
activity. The sequence of MCoCC-1 is significantly different from
the previously characterized trypsin inhibitors. However, a lysine
residue, present in loop 1 of the trypsin inhibitors MCoTI-I, MCoTI-
II, and MCoTI-III, which forms the primary trypsin recognition
site, is also present in MCoCC-1, albeit located in a slightly different
position. Despite the presence of this Lys in loop 1, no trypsin
inhibitory effect was observed for MCoCC-1 within the 0.04-0.5
µM range.
Hemolytic assays were conducted to examine the effect of
MCoCC-1 on human erythrocytes, as hemolytic peptides are not
appropriate candidates for drug design. The percentage of hemolysis
associated with the incubation of red blood cells with MCoCC-1
was examined and compared to melittin, a highly hemolytic peptide
from honey bee venom.27 The extent of hemolysis caused by
melittin increased sharply between 2.5 and 20 µM, as expected for
this positive control, whereas no hemolysis was observed for
MCoCC-1 up to 50 µM.
The lack of toxicity on erythrocytes and lack of trypsin inhibitory
activity pose the question of the natural function of MCoCC-1.
There are several examples of plant-derived peptides of similar size
(i.e., ∼30 amino acids) displaying insecticidal activity, including
the cyclotides kalata B128 and kalata B229 and plant defensins.30
Although MCoCC-1 has a different sequence than these other
peptides, its plant origin and disulfide-rich structure in common
with the cyclotides meant that it was of interest to test it for
insecticidal activity. MCoCC-1 was tested against the insect species
HelicoVerpa armigera, which, along with other species in the
HelicoVerpa genus, is a major pest in cotton and other commercial
crops, such as corn and sorghum. H. armigera larvae were tested
in feeding trials starting at the late second to early third instar
developmental stage because more visible effects from changes in
diet can be observed at this stage. Larvae were divided into three
groups and given different diets: a control diet, a diet containing
an O. affinis extract, and a diet containing MCoCC-1. The control
diet consisted of soy flour and wheat germ without the addition of
peptide.29 O. affinis extract was added to a second diet as a positive
control, since it has previously been shown to display insecticidal
activity.28 Analysis of the weights of larvae over a feeding period
of 96 h revealed that larvae fed with a diet containing MCoCC-1
gained more weight than larvae fed with the O. affinis extract diet.
In contrast, larvae fed with the control diet and larvae fed with the
diet containing MCoCC-1 showed similar results, indicating that
MCoCC-1 does not have an insecticidal effect.
A comparison of the surfaces of MCoCC-1 and kalata B1 is given
in Figure 6 and helps to explain why no insecticidal effect is seen for
MCoCC-1. The surface-exposed hydrophobic residues of kalata B1
have been shown to be involved in membrane binding,31 and disruption
of the midgut membranes of insects fed kalata B1 is the presumed
mechanism of insecticidal action.32 Given the different locations of
the hydrophobic patches in the MCoCC-1 and kalata B1, it seems
unlikely that they have a similar mode of membrane binding.
In summary, we have discovered two novel peptides from M.
cochinchinensis seeds. They have no sequence homology to any
previously characterized peptides and display cytotoxicity effects
on cancer cell lines. MCoCC-1 likely contains a cystine knot motif,
a common structural feature that imparts considerable stability to
protein folds. MCoCC-1 is not hemolytic and, unlike peptides
Table 2. Structural Statistics of MCoCC-1 Structures Calculated with Alternative Disulfide Restraints
disulfide connectivities NOE energy (kJ mol-1) dihedral energy (kJ mol-1) overall energy (kJ mol-1)
no disulfide connectivities 14.44 ( 2.61 1.08 ( 0.73 -1159.58 ( 19.07
2-13, 7-19, 17-30 (set 1) 13.43 ( 4.34 2.51 ( 0.91 -1116.88 ( 6.64
2-30, 7-19, 13-17 (set 2) 20.08 ( 5.55 1.66 ( 1.14 -1110.57 ( 23.61
2-17, 7-19, 13-30 (set 3) 12.00 ( 3.22 0.69 ( 0.28 -1186.40 ( 14.25
2-17, 7-30, 13-19 (set 4) 14.16 ( 3.05 1.45 ( 0.55 -1168.04 ( 9.66
Figure 5. Cytotoxicity of purified MCoCC-1, MCoCC-2, and a
M. cochinchinensis seed extract. Three cancer cell lines were used
in the assays: a human colorectal adenocarcinoma cell line (HT29;
green); a human lung carcinoma cell line (A549; orange); and a
human melanoma cell line (MM96L; pink). Neonatal foreskin
fibroblast cells were used as a noncancerous control (NFF; blue).
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previously characterized from M. cochinchinensis seeds, does not
have trypsin inhibitory activity. Overall, this study has expanded
knowledge on M. cochinchinensis peptides and contributes to the
field of cystine knot peptides.
Experimental Section
General Experimental Procedures. UV spectra were measured
on a Varian Cary 50 UV visible spectrophotometer. 1D and 2D
NMR spectra were recorded on both Bruker Avance 500 and 600
MHz spectrometers. Data were processed using TOPSIN (Bruker). Mass
spectrometry data were obtained using a Micromass LCT mass
spectrometer. MALDI-TOFMS analysis was carried out using a
Voyager DE-STR mass spectrometer (Applied Biosystems). Data were
collected between 500 and 4000 Da. Peptide sequencing was conducted
using nanospray MS/MS on a QStar mass spectrometer. Ion spray
voltage was applied at 900 V, and collision energy between 10 and 50
V was applied for peptide fragmentation. Data processing and acquisi-
tion were done using the Analyst software program with spectra
acquired at m/z 400-2000 for TOF spectra and m/z 60-2000 for
product ion spectra. RP-HPLC was carried out using an Agilent 1100
series with a UV detector at variable wavelengths of 215, 254, and
280 nm and Waters 600 system controller with a Waters 484 tunable
absorbance detector at 215 nm.
Extraction of Peptides from the M. cochinchinensis Seed Extract.
The frozen ripe fruit of M. cochinchinensis was purchased from a
Vietnamese store in Melbourne, Australia. The fruit was thawed, and
the seeds were removed from the pulp and homogenized in the presence
of ice-cold NaOAc (20 mM, pH 5.0).10 The mixture was blended and
stirred overnight at 4 °C, before centrifugation for 30 min at 5343g.
The soluble fraction was stirred with an equal volume of ice-cold
acetone for 1 h, and the precipitate was removed using a Whatman
541 filter paper. The acetone was evaporated using a rotary evaporator,
and the final extract was freeze-dried.
Purification of Peptides from the M. cochinchinensis Seed
Extract. The peptides were purified to >95% purity from the dried M.
cochinchinensis seed extract by a series of RP-HPLC purifications on
Phenomenex C18 columns. Gradients of 1% min-1 of 0-60% solvent
B (90% MeCN in 0.045% TFA in H2O) from solvent A (aqueous 0.05%
TFA in H2O) were employed, and the eluant was monitored at 215
nm. The final purity of the peptides was examined by analytical RP-
HPLC on a Phenomenex Jupiter 5u C18 300 Å 150 × 2.0 mm column
and the mass assessed by electrospray mass spectrometry.
Sequencing of the Peptides Using Nanospray Mass Spectrometry.
The peptides from the M. cochinchinensis seed extract were sequenced
using nanospray MS-MS on a QStar mass spectrometer. Initially,
disulfide bonds of the peptides were reduced with TCEP. These peptides
were then digested with endoproteases, trypsin and chymotrypsin. The
digestions were quenched after 2 h by adding an equal volume of 0.5%
HCO2H and desalted using Ziptips (Millipore). Precursor ions from the
digested peptide were selected and sequenced via nanospray MS-MS.33
A voltage of 900 V was applied, and spectra were acquired in the range
m/z 60-2000 for both product ion and time-of-flight spectra. Collision
energy was applied between 10 and 50 V for ion fragmentation. The
composition of the peptide was then confirmed with high-sensitivity amino
acid analysis, which was conducted by the Australian Proteome Analysis
Facility Ltd. Peptide samples were hydrolyzed for 24 h with 6 N HCl at
110 °C, and amino acids were analyzed using the Waters AccQTag
chemistry. This analysis was performed in duplicate.
NMR Spectroscopy. Samples for 1H NMR measurements contained
∼2 mg of peptide in 90% H2O/10% D2O (v/v) at ∼pH 5.5. D2O (99.9%)
was obtained from Cambridge Isotope Laboratories, Woburn, MA.
Spectra were recorded at 290 K on both Bruker Avance 500 and Bruker
Avance 600 MHz spectrometers. One-dimensional 1H spectra were
acquired, followed by two-dimensional spectra, which included TOCSY,
NOESY, and DQF-COSY. Spectra were analyzed using the program
SPARKY.34 The sequential assignment procedure pioneered by
Wu¨thrich21 was initially used to sequence-specifically assign the amino
acids, using TOCSY and NOESY spectra. DQF-COSY spectra were
used to confirm the side chain assignments for several residues.
Structure Calculations. The three-dimensional structure was cal-
culated by deriving distance and angle restraints from the NOESY and
DQF-COSY spectra, respectively. A family of structures that are
consistent with the experimental restraints was calculated using the
programs CYANA35 and CNS.36 Preliminary structures were calculated
using CYANA and used to resolve ambiguities in the NOE assignments.
Once a complete set of input restraints (distance and dihedral angle
restraints) was determined, structures were calculated with a simulated
annealing protocol within the program CNS. A set of 50 structures
was calculated, and the 20 lowest energy structures were selected for
further analysis. Structures were analyzed using the programs
PROCHECK37 and PROMOTIF24 to generate statistical analyses, such
as a Ramachandran plot, from the structure calculations. The programs
MolMol38 and PyMol39 were used to display the structural ensembles
and surfaces of the proteins, respectively.
Partial Reduction of MCoCC-1 to Determine the Connectivity
of the Disulfide Bond. MCoCC-1 (∼100 µg) peptide was dissolved
with 100 µL of citrate buffer (0.2 M, pH 3). Freshly prepared tris(2-
carboxyethyl)phosphine hydrochloride (10 µL, 20 mM) was added to
10 µL of peptide solution and then incubated at 37 °C for 30 min in a
steam bath. Samples were analyzed on analytical RP-HPLC using a
2% gradient with 0.3 mL/min flow rate on a Phenomenex Jupiter 5u
C18 300 Å 150 × 2.0 mm column. The success of reduction of
MCoCC-1 was determined by a comparison of its oxidized and reduced
elution profiles. The elution profiles were overlaid to observe the
presence of any intermediates.
Cytotoxicity Assay. The cytotoxicity of MCoCC-1 and MCoCC-2
was tested on three human tumor cell lines, namely, the human
colorectal adenocarcinoma (HT29), human lung carcinoma cells (A549),
the human melanoma cell line (MM96L), and a noncancerous cell line,
neonatal foreskin fibroblast cells (NFF). These cell lines were chosen
because they have been used in recent cancer disease studies.40-42 All
cells were cultured in RPMI 1640 supplemented with 10% FBS at 37
°C, 5% CO2, and 99% humidity. Cells were seeded into individual
wells of the 96-well tissue culture plates (5000 cells/well) and grown
for 24 h prior to treatment. The peptides were dissolved in H2O and
diluted in culture medium. Cells were treated with 0.02, 0.07, 0.2, 0.7,
2.0, and 7 µg/mL and no peptide (culture media only).43 Three days
after treatment initiation, cells were washed with phosphate-buffered
saline (PBS) and fixed with methylated spirits, and total protein was
determined using sulforhodamine B as described in Skehan et al.44
Cytotoxicity was calculated as a percentage of the nonpeptide-treated
control cell protein, where 100% of control represented 100% cell
survival. All treatments were performed in triplicate, and each experi-
ment was performed in duplicate.
Trypsin Inhibitor Assay. A stock solution of NR-benzoyl-DL-
arginine 4-nitroanilide (BAPNA) was prepared at 2 mg/mL and stored
on ice. Immediately prior to use, a stock solution of trypsin was prepared
(10 mg/mL in H2O). The substrate (chicken trypsin inhibitor) was
prepared by dissolving 1.5 mg/mL in distilled water. Four samples were
tested in this assay: 1 (0.21 µM stock) and 10 µL (2.1 µM stock) of
MCoCC-1, 10 µL of chicken trypsin inhibitor (a positive control), and
20 µL of trypsin solution (a negative control). Each Eppendorf tube
Figure 6. Comparison of surface features of MCoCC-1 and the
insecticidal plant peptide kalata B1. Hydrophobic residues are
shown in green, and selected amino acids are labeled. The ball and
stick diagrams on the right highlight the common orientation of
the peptides. Kalata B1 has been shown to involve membrane
binding via a surface-exposed hydrophobic patch in its mechanism
of insecticidal activity.32 The different molecular surface of
MCoCC-1, despite a similar overall fold, explains its lack of
insecticidal activity.
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consisted of 20 µL of trypsin solution, 40 µL of BAPNA, variable
volume of test compounds as noted above, and a buffer of 50 mM
tris-HCl pH 7.4; 10 mM CaCl2 was added to make up a total volume
of 600 µL. BAPNA was added last after 1.5 min of incubation at room
temperature. A sample that contained only trypsin solution was used
to measure 100% trypsin activity. Absorbance readings were obtained
at 410 nm using a CARY-50 UV-visible spectrophotometer (Varian).
The assay was performed in triplicate.
Hemolytic Assay. Peptides were prepared by two serial dilutions
with PBS as previously described.16,34 Human red blood cells (RBCs)
were washed with PBS and centrifuged repeatedly at 1500g for 1 min
until a clear supernatant was obtained. Synthetic melittin was used as
a positive control due to its high hemolytic activity. Twenty microliters
of each peptide solution, melittin, or 1% Triton X-100 was added to
100 µL of 0.25% suspension of washed RBCs in PBS. The highest
test concentration for the peptides and synthetic melittin (Sigma)
solutions was 50 and 20 µM, respectively. The plate was incubated at
37 °C for 1 h and centrifuged at approximately 150g for 5 min using
a plate centrifuge. The supernatant (100 µL) was transferred out of
each well into a 96-well, flat-bottomed plate, and the absorbance was
measured at 415 nm (Multiskan Ascent plate reader, Labsystems).
Hemolysis was calculated as the percentage of maximum lysis (Triton
X-100) and was plotted using GraphPad Prism software.
Insecticidal Assay. H. armigera larvae were obtained from the
Queensland Department of Primary Industries (QDPI). A feeding trial
adapted from one reported recently32 was conducted for 96 h; larvae
were kept at 25 °C throughout the experiment. Larvae were given one
of three diets and were tested in triplicate. All diets contained mainly
wheat germ, yeast, and soy flour. The control diet did not have any
added peptide. Jennings et al.28 showed that pure kalata B1 from O.
affinis extract had insecticidal activity on larvae; hence a diet containing
O. affinis extract was used as a positive control. The quantity of O.
affinis extract in the diet was equivalent to a calculated content of 0.825
µmol of kalata B1. The third diet contained approximately 0.825 µmol
of MCoCC-1. Initially each larva was weighed and starved for 6 h in
an individual Eppendorf tube with holes. On the sixth hour each larva
was transferred into a feeding container, given 300 mg of their
respective diet, and allowed to feed for 96 h. Each larva was weighed
after the first feeding on the 24th hour and again at 24 h intervals until
the end of this feeding trial. Following this, the larvae, remaining diet,
and frass were weighed and photographed.
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